Sri Trang Gloves (Thailand) Valuation
Is STGT-R undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of STGT-R when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: STGT-R (THB9.25) is trading above our estimate of fair value (THB2.81)
Significantly Below Fair Value: STGT-R is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for STGT-R?
Other financial metrics that can be useful for relative valuation.
What is STGT-R's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | ฿26.50b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 1.2x |
Enterprise Value/EBITDA | 14.1x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does STGT-R's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 3.2x | ||
TOG Thai Optical Group | 1.7x | n/a | ฿5.3b |
SKR Sikarin | 3.6x | n/a | ฿21.0b |
CHG Chularat Hospital | 4x | 7.8% | ฿31.9b |
VIBHA Vibhavadi Medical Center | 3.6x | n/a | ฿30.3b |
STGT-R Sri Trang Gloves (Thailand) | 1.3x | 13.3% | ฿26.5b |
Price-To-Sales vs Peers: STGT-R is good value based on its Price-To-Sales Ratio (1.3x) compared to the peer average (3.2x).
Price to Earnings Ratio vs Industry
How does STGT-R's PE Ratio compare vs other companies in the Asian Medical Equipment Industry?
Price-To-Sales vs Industry: STGT-R is good value based on its Price-To-Sales Ratio (1.3x) compared to the Asian Medical Equipment industry average (3.3x).
Price to Sales Ratio vs Fair Ratio
What is STGT-R's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 1.3x |
Fair PS Ratio | 2.3x |
Price-To-Sales vs Fair Ratio: STGT-R is good value based on its Price-To-Sales Ratio (1.3x) compared to the estimated Fair Price-To-Sales Ratio (2.3x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.